Director/PDMR Shareholding
28/04/2023 14:58
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230428:nRSb9282Xa&default-theme=true
RNS Number : 9282X Medica Group PLC 28 April 2023
Medica Group PLC
Director / PDMR Shareholding
Medica Group PLC (the "Company") announces that on 28 April 2023, the PDMRs
listed below were granted options over ordinary shares of 0.2p each in the
Company under the Company's Performance Share Plan 2017 at a nil exercise
price:
Name of PDMR Number of shares subject to option
Stuart Quin 290,594
Richard Jones 205,125
Kevin Terrins 143,081
Sarah Burns 143,081
Marc O'Brien 153,844
Caroline Byrne 99,329
Rob Lavis 140,897
Fiona Carr 82,154
Kim Scanlan 158,321
The notifications set out below are provided in accordance with the
requirements of the UK Market Abuse Regulation, and set out more details of
the transactions.
1. Details of PDMR
(a) Name 1. Stuart Quin
2. Richard Jones
3. Kevin Terrins
4. Sarah Burns
5. Marc O'Brien
6. Caroline Byrne
7. Rob Lavis
8. Fiona Carr
9. Kim Scanlan
2. Reason for notification
(b) Position / status 1. Chief Executive Officer
2. Chief Financial Officer
3. Group Director of Corporate Development
4. Managing Director, UK
5. Chief Information Officer
6. Managing Director, Ireland
7. Group Medical Director
8. Group Head of Human Resources
9. Managing Director, US
Initial notification / amendment Initial notification in each case
3. Details of the Issuer
(a) Name Medica Group PLC
(b) LEI 213800B8XE5FUSZF5Z16
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transaction(s) have been conducted
(a) Description of the financial instrument Ordinary shares of 0.2p each in the capital of the Company ("Shares")
(b) Nature of the transaction Grant of options to acquire Shares pursuant to the Company's Performance Share
Plan 2017
(c) Price(s) and volume Option Price nil in each case
1. 290,594
2. 205,125
3. 143,081
4. 143,081
5. 153,844
6. 99,329
7. 140,897
8. 82,154
9. 158,321
(d) Aggregated information N/A
(e) Date of the transaction 28 April 2023
(f) Place of the transaction Outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHNKFBPNBKDAQB